Drug Development
From Monoliths to Ecosystems
The new R&D paradigm
Historically pharmaceutical innovation was concentrated among a small number of large companies
Precision Medicine
Redefining genomic breakthroughs and 3D printing in pharmaceutical R&D
Precision medicine PM is aimed at significantly reforming the pharmaceutical industry through advancements
Drug Discovery Today
Looking back, looking forward
While recently attending by invitation a stateoftheart ChimeraX workshop on molecular modelling at the Harvard Medical School
Advanced Drug Delivery Strategies for Inflammatory Bowel Disease
Crohns Disease CD and Ulcerative Colitis UC are the two main forms of IBD affecting more than million people worldwide
Top Use Cases for Artificial Intelligence, Machine Learning, and Blockchain within Drug Development
The drug development process from discovery to market is an overly complex inefficient lengthy
Understanding Disease Progression and Immune Response Using CyTOF Technology to Accelerate Drug Development
The biology of disease can be confounding While some singlesource diseases can be accurately predicted
Advanced Drug Delivery Systems to Address Unmet Medical Needs
Progress in the field of molecular pharmacology and improved understanding of disease pathophysiology
Powering Decentralised Drug Development
Enabling downstream disruptive technologies to generate high fidelity output
The Decentralised Drug Development DDD process involves coordinating various vendors and pulling together contract research organisations
Recent Advances in Small-molecule Broad-spectrum Inhibitors of Bacterial Metallo-β-lactamases
Incessant resistance of pathogenic bacteria to almost all forms of antibiotics continues to pose a major threat to human wellbeing worldwide
FROM DISCOVERY TO DELIVERY
Neuronal exosomes and the evolution of neurodegenerative disease treatment
The rising challenge of Neurodegenerative diseases NDDs including Alzheimers Parkinsons Huntingtons disease
